Renaissance Technologies Portfolio: Top 10 Stock Picks
The American quant hedge fund Renaissance Technologies is known for using statistical and mathematical tools to drive its investment programs.
Posts Tagged ‘NASDAQ:GILD’
10 Stocks That Analysts Think Will Go Up
The S&P 500 index touched an all-time high this week as Mark Zuckerberg’s company's 20-day streak finally came to an end, adding $320 billion to the company’s market cap.
Gilead Sciences, Inc. (GILD): A Bull Case Theory
We came across a bullish thesis on Gilead Sciences, Inc. (GILD) on Substack by Disruptive analytics. In this article, we will summarize the bulls’ thesis on GILD.
Gilead Sciences, Inc. (NASDAQ:GILD) Q4 2024 Earnings Call Transcript
Gilead Sciences, Inc. (NASDAQ:GILD) Q4 2024 Earnings Call Transcript February 11, 2025Gilead Sciences, Inc. beats earnings expectations.
Why Gilead (GILD) Is Advancing Today
Drug maker Gilead (GILD) is rallying 7.5% after the company reported stronger-than-expected fourth-quarter results and provided 2025 earnings per share guidance that came in above...
10 Best Wide Moat Stocks to Invest In
Russell Investments continues to monitor and analyze the potential for policy changes in President Trump's second term in office.
10 AI News and Ratings You Should Not Miss
DeepSeek is making significant strides in the artificial intelligence landscape.
8 Best Humane Stocks to Invest in Now
In recent years, the investment landscape has seen a significant shift towards socially responsible investing strategies.
Billionaire Steve Cohen’s Top 15 Stock Picks
Steve Cohen is one of the most prominent and successful hedge fund managers in the world, known for his extraordinary trading acumen and ability to generate consistent returns...
15 Best NASDAQ Dividend Stocks To Buy
The NASDAQ, heavily comprised of technology stocks, has been on a consistent upward trajectory for some years.
Here’s Why TCW Relative Value Large Cap Fund Exited its Position in Gilead Sciences (GILD)
TCW Funds, an investment management company, released its “TCW Relative Value Large Cap Fund” Q3 2024 investor letter. A copy of the letter can be downloaded here.
Gilead Sciences, Inc. (GILD): A Bull Case Theory
We came across a bullish thesis on Gilead Sciences, Inc. (NASDAQ:GILD) on Substack by Magnus Ofstad. In this article, we will summarize the bulls’ thesis on GILD.
Top 20 Dividend Stocks of 2024
Macroeconomic factors have weighed on US stocks in the final days of the year, with the broader market declining by over 1% in the past week.
13 Best Pharma Dividend Stocks To Buy In 2024
The pharmaceutical industry in 2024 faced a relatively quiet year, with deal volumes similar to 2023 but lower deal values, reflecting a shift toward smaller, more strategic transactions...
Jim Cramer Talked About These 8 Stocks
Jim Cramer, host of Mad Money, recently shared some investment wisdom drawn from his four decades of experience.
Gilead Sciences (GILD) Made Big Announcements in Q3
Polaris Capital Management, an investment management company, released its third quarter 2024 investor letter. A copy of the same can be downloaded here.
Gilead Sciences, Inc. (NASDAQ:GILD) Q3 2024 Earnings Call Transcript
Gilead Sciences, Inc. (NASDAQ:GILD) Q3 2024 Earnings Call Transcript November 6, 2024Gilead Sciences, Inc. beats earnings expectations.
10 Best Pharma Stocks To Buy Right Now
Healthcare takes the concept of 'defensive' further than almost any industry, encompassing many companies that provide patient care, engage in the research and development of ...
Goldman Sachs’ Stocks With Highest Consensus Returns: 42 Stocks With The Highest Consensus ROE
As the fourth quarter of 2024 settles in, the narrative surrounding stocks on Wall Street is starting to shift.
Goldman Sachs’ List Of Stocks Popular With Mutual Fund Managers: Top 20 Stocks
As the fourth quarter of 2024 starts, the market is once again back to debating about the Federal Reserve's interest rate cuts.
Gilead Sciences, Inc. (NASDAQ:GILD) Q2 2024 Earnings Call Transcript
Gilead Sciences, Inc. (NASDAQ:GILD) Q2 2024 Earnings Call Transcript August 8, 2024Gilead Sciences, Inc. beats earnings expectations.
Should You Hold Gilead Sciences (GILD)?
Parnassus Investments, an investment management company, released the “Parnassus Value Equity Fund” first quarter 2024 investor letter.
Hedge Funds are Bullish on This Gene Therapy Stock
We recently compiled a list of the 9 Best Gene Therapy Stocks to Buy Now and in this article, we discuss Gilead Sciences, Inc.
9 Best Gene Therapy Stocks to Buy Now
In this article, we will be discussing the best gene therapy stocks to buy now. Before we move on to our list, let's take a look at the market outlook for gene therapies and ...
23 Most Profitable Stocks of the Last 12 Months
In this article, we discuss the 23 most profitable stocks of the last 12 months.
Gilead Sciences, Inc. (NASDAQ:GILD) Q1 2024 Earnings Call Transcript
Gilead Sciences, Inc. beats earnings expectations. Reported EPS is $-1.32, expectations were $-1.49. Gilead Sciences, Inc.
5 Best Depressed Stocks To Buy in 2024
This article presents an overview of 5 Best Depressed Stocks To Buy in 2024. For a detailed overview of such stocks read our article, 12 Best Depressed Stocks To Buy in 2024...
5 Best High-Dividend Stocks to Buy Right Now
In this article, we discuss 5 best high-dividend stocks to buy right now.
12 Most Profitable Biotech Stocks To Invest In
In this piece, we will take a look at the 12 most profitable biotech stocks to invest in.
15 Best NASDAQ Dividend Stocks To Buy
In this article, we discuss 15 best NASDAQ dividend stocks to buy.
20 Fastest Growing Biotech Companies in the US
In this article, we will be taking a look at the 20 fastest growing biotech companies in the US.
Top 5 CRISPR Stocks To Invest In
In this article, we discuss the top 5 CRISPR stocks to invest in.
30 Most Valuable Drug Companies in 2024
In this article, we will take a look at the 30 most valuable drug companies in 2024.
Gilead Sciences, Inc. (NASDAQ:GILD) Q4 2023 Earnings Call Transcript
Operator: Good afternoon. Thank you for attending the Four Quarter and Full Year 2023 Gilead Sciences Earning Conference Call.
16 Most Undervalued Quality Stocks To Buy According To Hedge Funds
In this article, we will take a detailed look at the 16 Most Undervalued Quality Stocks To Buy According To Hedge Funds. For a quick overview of such stocks, read our article...
What Makes Gilead Sciences (GILD) an Attractive Investment?
ClearBridge Investments, an investment management company, released its “ClearBridge Dividend Strategy” fourth quarter 2023 investor letter.
12 Best Stocks to Buy for an 18 Year Old
In this article, we discuss the 12 best stocks to buy for an 18 year old.
13 Most Profitable Pharmaceutical Stocks Now
In this article, we discuss the 13 most profitable pharmaceutical stocks to buy.
5 Best Non-REIT Dividend Stocks To Invest In
In this article, we discuss 5 best non-REIT dividend stocks to invest in.
30 Largest Pharmaceutical Companies in the World
In this article, we will be taking a look at the 30 largest pharmaceutical companies in the world.
5 Best High Yield Stocks To Buy
In this article, we discuss 5 best high-yield stocks to buy.
15 Best Drug Stocks To Invest In
In this article, we discuss the 15 best drug stocks to invest in.
20 Most Valuable Healthcare Companies in the World
In this article, we will look into the 20 most valuable healthcare companies in the world.
Jim Simons Stock Portfolio: 5 Biggest Healthcare Stocks
In this piece, we will take a look at the five biggest healthcare stocks in Jim Simons' stock portfolio.
Top 20 Drug Companies in the US by Revenue
In this article, we will be taking a look at the top 20 drug companies in the US by revenue.
Gilead Sciences, Inc. (NASDAQ:GILD) Q3 2023 Earnings Call Transcript
Operator: Hello everyone and welcome to the Third Quarter 2023 Gilead Sciences' Earnings Conference Call. My name is Nadia and I'll be coordinating the call today.
11 Best Pharma Stocks To Buy Now
In this article, we discuss the 12 best pharma stocks to buy now.
Jim Simons Stock Portfolio: Top 10 Stock Picks
In this piece, we will take a look at Jim Simons' stock portfolio and the top ten stock picks.
Top 30 Oncology Companies in the World
In this article, we shall cover the top 30 oncology companies in the world.
AQR Capital Management: AUM, Performance, Stock Picks
In this article, we looked at Cliff Asness' investment philosophy and outlook on the US stock market.
